Pfizer reports positive results in trial of vaccine for immunocompromised adults at risk of severe RSV-related illnessMarket Watch • 08/12/24
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised AdultsBusiness Wire • 08/12/24
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With $100 NowThe Motley Fool • 08/12/24
Want to Earn $1,000 in Annual Dividend Income? Invest $11,300 in These 3 High-Yield StocksThe Motley Fool • 08/10/24
Dividend Harvesting Portfolio Week 179: $17,900 Allocated, $1,638.21 In Projected DividendsSeeking Alpha • 08/08/24
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold ForeverThe Motley Fool • 08/06/24
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer ProductsBenzinga • 08/05/24
Investing $100,000 in These 7 High-Yield Dividend Stocks Could Generate Over $7,000 in Annual Passive IncomeThe Motley Fool • 08/04/24